Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEUCOPRO: 99mTc-HMPAO SPECT-CT for Vascular Prosthesis Infection
NCT02538133Phase 3Unknown
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Sep 2015
- Primary completion
- Jan 2020
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 3 trial of technetium-99m hexamethylpropylene amine oxime in Vascular prosthesis infection (PVGI), sponsored by Centre Hospitalier Universitaire d'Angers. Status: unknown.
02
Drugs
technetium-99m hexamethylpropylene amine oxime
03
Conditions
Vascular prosthesis infection (PVGI)
Beyond the preview
Go deeper on NCT02538133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02538133.